Argenx to present at upcoming investor conferences

August 30 , 202 3 amsterdam , the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in several upcoming investor conferences in september:

ARGX Ratings Summary

ARGX Quant Ranking